Research Community Ready for Open Source Drug Discovery [Editorial]

In an Editorial to the Canadian Science Policy Centre, Drs. Aled Edwards and Aidan Hollis describe the need for Open Source Drug Discovery to address the inefficiencies in developing new drugs and the resulting exorbitant prices of new medicines. The support for M4K Pharma indicates the research community is ready for an open science business model of drug discovery.

For the full article: http://sciencepolicy.ca/news/open-source-drug-discovery

Previous
Previous

SGC Open Notebookers Share DIPG Drug Discovery Research in Real Time

Next
Next

OICR’s CTIP Initiative Funds M4K’s DIPG Program